Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 13/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.50 |
| ▸ | BCL9 | O00512 | 3/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | PTGES | O14684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | PNLIP | P16233 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29713175 | 0.89 | FDPS (0.57) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL6658577 | 0.76 | FDPS (0.80) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL29405917 | 0.75 | FDPS (0.80) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL9923660 | 0.75 | FDPS (0.80) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL20225083 | 0.70 | FDPS (0.37) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL30726729 | 0.69 | FDPS (0.77) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL32659910 | 0.69 | FDPS (0.70) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| Methyl Carnosate SCHEMBL29426661 | 0.67 | FDPS (1.00) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL25937959 | 0.66 | FDPS (0.39) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| Ferruginol SCHEMBL13423521 | 0.65 | KARS1 (0.73) | FDPSGGPS1BCL9CTNNB1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240316135-A1 | ORALLY CONSUMABLE COMPOSITION WITH PLANT EXTRACT | THE COCA-COLA COMPANY | 2024-09-26 | — | — | US | disclosed |
| EP-4358741-A1 | ORALLY CONSUMABLE COMPOSITION WITH PLANT EXTRACT | The Coca-Cola Company (US) | 2024-05-01 | — | — | EP | disclosed |
| US-20230027219-A1 | Skin Care Compositions and Methods of Use Thereof | UNIGEN, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| WO-2022272114-A1 | ORALLY CONSUMABLE COMPOSITION WITH PLANT EXTRACT | THE COCA-COLA COMPANY (US) | 2022-12-29 | — | — | WO | disclosed |
| US-11446225-B2 | Skin care compositions and methods of use thereof | UNIGEN, INC. (US) | 2022-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027219-A1 | Skin Care Compositions and Methods of Use Thereof | CUTA, LGALS8, RBP1 | FDPS 4632/4885GGPS1 4717/4885BCL9 2637/4885 |
| US-20240316135-A1 | ORALLY CONSUMABLE COMPOSITION WITH PLANT EXTRACT | PYGB, CHAT, CALCOCO2 | FDPS 2568/4885GGPS1 1869/4885BCL9 3719/4885 |
| US-11446225-B2 | Skin care compositions and methods of use thereof | CUTA, LGALS8, RBP1 | FDPS 4632/4885GGPS1 4717/4885BCL9 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.